Deborah Farina
Chieti, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study.
Journal: European journal of neurology
Published: October 29, 2020
Data of safety in a single-center alemtuzumab treated population.
Journal: Data in brief
Published: November 29, 2019
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center.
Journal: Multiple sclerosis and related disorders
Published: April 02, 2019
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study.
Journal: Journal of neurology
Published: August 30, 2018
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: January 24, 2018
Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
Journal: Annals of neurology
Published: November 24, 2015
Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial.
Journal: Health expectations : an international journal of public participation in health care and health policy
Published: November 02, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026